Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients

NCT04188418 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT04188418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04188418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 23, 2020
Completion date
August 31, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic and lymphoid cell neoplasm, malignant solid neoplasm